The Annexure

News to 9 October 2026 ·

Desk›Healthcare› Biofil Chemicals & Pharmaceuticals Ltd

Biofil Chemicals & Pharmaceuticals Ltd

BSE 524396 · NSE BIOFILCHEM · ISIN INE829A01014 · Group B · Active

Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals

₹33.03

+0.85%

BSE close, 28 August 2026

Market cap

₹53.75 cr

1.6 cr shares · Micro cap

Free float

₹28.60 cr

as published

P/E · P/B

110.1× · 2.92×

EPS ₹0.30 · BV ₹11.31

FY25-26 rev / PAT

28.40 / 2.79

₹ cr, as filed

Filings, window

15

4 selected · 27%

Regime

Reg 30

Sch. III Part A

Price 52-week, BSE

52-WK LOW ₹25.60 52-WK HIGH ₹46.82 ₹33.03 35% of range
Against 52-week high-29.5%
Against 52-week low+29.0%
Day change+0.85%
Size bandMicro cap
Index membershipNone

Valuation as published by BSE

Earnings per share₹0.30
Price / earnings110.10×
Price / book2.92×
Book value — derived, price ÷ P/B₹11.31
Return on equity2.63%
Operating margin1.64%
Net margin0.88%

Consistency check

P/B ÷ P/E, which must equal ROE
2.65%
ROE as published
2.63%

Results ₹ crore, as filed

RevenueNet profit one scale across all three periods, ₹ crore

PeriodRevenue ₹cr Net profit ₹cr EPS ₹OPM NPM
Jun-26 · Q 12.35 0.11 0.07 1.64% 0.88%
Mar-26 · Q 7.57 0.21 0.13 7.18% 2.80%
FY25-26 28.40 2.79 1.71 13.14% 9.81%

Quarter on quarter

Revenue, quarter on quarter
+63.1%
Net profit, quarter on quarter
-47.6%
Operating margin, quarter on quarter
-554 bps

Disclosure profile 15 filings in the window

0 median 17.0 p75 · 25 sector max 52 15 43th percentile of 300 Healthcare filers
Shaded is the middle half of the sector, 12 to 25 filings. Measured against the 300 Healthcare companies that filed at all in this window — companies with no filings are excluded, so this is a percentile against filers rather than against the sector.
TagFilings
Selected
Change in Management2
Board Outcome1
Results1
Selected sub-total4
Procedural
AGM / EGM4
Newspaper Publication3
Annual Report1
Compliance Certificate1
General1
Trading Window1
Procedural sub-total11
Total15

Disclosure regime

LODR Reg 30

Read with Schedule III Part A. An equity filer in BSE Group B, so the Regulation 30 disclosure framework and the Schedule III event list both apply.

Sources Price, day change, 52-week range — bse.quote, bse.quoteWeeklyHL, 28 August 2026 close. Market cap and free float — bse.getScripTradingStats. P/E, P/B, EPS, ROE, margins — bse.equityMetaInfo. Quarterly and annual results — bse.resultsSnapshot, standalone, as filed. Four-tier classification — data/reference/companies.csv. Filing counts and tags — the build aggregate for this window. Notes Book value is derived as price ÷ P/B; BSE does not publish it directly. Share count is derived as market cap ÷ price. Figures move between captures and between vendors, and the two are not an error in either: companies.csv carries the market cap from an earlier sweep than the snapshot above. EPS appears twice with different meanings — the figure beside P/E is the trailing one from equityMetaInfo, while the EPS in the results table is the per-period figure as filed.

Filing rhythm · 93 trading days

15 filings · 4 selected · busiest 2026-08-26

Filing rhythm · the twelve most recent

2026-08-122026-10-06

SelectedProcedural

Filings

15 in the window · 2 earlier on record

  1. 6 October 2026 ·

    Compliance Certificate

    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    Certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depository and Participants) Regulations, 2018 for the quarter ended 30th September, 2026

    Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

  2. 24 September 2026 ·

    Trading Window

    Closure of Trading Window

    Intimation of closure of Trading window with effect from Thursday, 01st October 2026

    Insider Trading / SAST / Closure of Trading Window View filing →

  3. 24 September 2026 ·

    Change in Management

    Change in Management

    Continuous disclosure of Material event or information for which disclosure as required under sub-clause 7 of Part A Para A Schedule III : 1 .Continuation of directorship of Mr. Ashok ....

    Company Update / Change in Management View filing →

  4. 24 September 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    Scruitinizer report with voting results

    AGM/EGM / AGM View filing →

  5. 23 September 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Outcome of AGM

    Summary of Proceedings of 41st Annual General Meeting of the company held on Wednesday, 23rd September 2026 pursuant to Regulation 30 read with Para A of Part A of Schedule III of SEBI ....

    AGM/EGM / AGM View filing →

  6. 28 August 2026 ·

    Newspaper Publication

    Newspaper Publication

    Pursuant to Regulation 30, 44 and 47 of SEBI(LODR) Regulations, 2015 and in compliance with Section 108 of the Companies Act, 2013 read with rule 20 of Companies (Management and Administration) ....

    Company Update / Newspaper Publication View filing →

  7. 26 August 2026 ·

    AGM / EGM

    Information Regarding E-Voting For 41St Annual General Meeting

    Information under Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Section 108 of the Companies Act, 2013 regarding voting through electronic ....

    AGM/EGM / AGM View filing →

  8. 26 August 2026 ·

    General

    Intimation For Dispatch Of Letter To Those Shareholders Whose E-Mail Addresses Are Not Registered With Company/Registrar & Transfer Agent/Depository Participants

    Intimation for Dispatch of letter to those shareholders whose e-mail addresses are not registered with company/ registrar and share transfer agent/ depository participants

    Company Update / General View filing →

  9. 26 August 2026 ·

    Annual Report

    Reg. 34 (1) Annual Report.

    Submission of Integrated Annual Report for the Financial Year 2025-26 along with Notice convening the 41st Annual General Meeting as per Regulation 34 of SEBI (Listing Obligations and Disclosure ....

    Others / Reg. 34 (1) Annual Report View filing →

  10. 26 August 2026 ·

    AGM / EGM

    Submission Of Notice Of Convening 41St AGM Of The Company.

    Submission of Notice of 41st AGM scheduled to be held on Wednesday 23rd September 2026 at 3:00 P.M. (IST) through video conferencing (VC)/ Other audio-visual means (OAVM)

    AGM/EGM / AGM View filing →

  11. 19 August 2026 ·

    Newspaper Publication

    Newspaper Publication

    Newspaper publication of Notice of 41st AGM through Video Conferencing ('VC')/ Other Audio Visual Means ('OAVM')

    Company Update / Newspaper Publication View filing →

  12. 12 August 2026 ·

    Newspaper Publication

    Newspaper Publication

    Submission of publication of Un-audited Financial Results in the Newspaper pursuant to Regulation 47 of SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015

    Company Update / Newspaper Publication View filing →

  13. 11 August 2026 ·

    Change in Management

    Change in Management

    Continuation of Directorship of Mr. Ashok Kumar Ramawat (DIN: 08818263) as a Non-executive Independent Director of the company, notwithstanding his attaining the age of 75 (Seventy Five )Years

    Company Update / Change in Management View filing →

  14. 11 August 2026 ·

    Results

    Un-Audited Financial Results For The Quarter Ended 30Th June 2026

    Un-Audited Financial Results for the quarter ended 30th June 2026

    Result / Financial Results View filing →

  15. 11 August 2026 ·

    Board Outcome

    Board Meeting Outcome for Outcome Of Board Meeting Held On Tuesday 11Th August, 2026 Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

    Outcome of Board Meeting held on Tuesday 11th August, 2026 pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

    Board Meeting / Outcome of Board Meeting View filing →

RSS feed for Biofil Chemicals & Pharmaceuticals Ltd · the 50 most recent filings